Stem Cell Theranostics, Inc.

REDWOOD CITY, CA 94063

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $300K
First Award Date 01/01/16
Most Recent Award Date 02/01/17

Key Personnel

Last Name Name Awards Contact
Lam Jason T Lam 2 Message
SANCHEZ FREIRE VERONICA SANCHEZ 1

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 02/01/17 - 07/31/17

Abstract This proposed NIH SBIR Phase I Project by Stem Cell Theranostics (SCT) is aimed at developing a novel in vitro pre-clinical screening platform to predict drug-induced cardiotoxicity. Cardiotoxicity is the most serious adverse drug reaction in clinical development and a leading cause of late stage drug failures. The pharmaceutical indust...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BT
Budget: 01/01/16 - 06/30/16

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop a stem cell-based platform to screen drugs for treating hypertrophic cardiomyopathy (HCM). The global economic burden of heart failure is a staggering $110B per year, touching the lives of nearly everyone. Stem cell-derived disease mod...